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Methylglyoxal may be involved in the early stages of decline in 
glucose tolerance and decline in pancreatic beta-cell function 
leading to type 2 diabetes. Methylglyoxal and methylglyoxal-
modified proteins increase during short-term increases in 
glucose concentration, infusion of exogenous methylglyoxal 
in rats and mice impaired glucose tolerance and glyoxalase 1 
(Glo1) prevented beta-cell toxicity. We investigated the role of 
methylglyoxal and protein glycation on beta-cell function and the 
development of diabetes, with focus on the interactions of cells 
with the extracellular matrix. Impairments in adhesion of MIN6 
insulinoma cells to methylglyoxal-glycated collagen IV were 
assessed in vitro using atomic force microscopy force spectros-
copy and methylglyoxal glycation adducts within the pancreas 
visualised by immunostaining. Minimal glycation of collagen IV at 
integrin binding sites impaired binding of MIN6 cells in vitro and 
resulted in a 91% decrease in the energy necessary to detach 
the cells from collagen. Evidence from high fat diet fed mice 
showed that the methylglyoxal concentration of the pancreas was 
increased in the insulin resistant, pre-diabetic state with methylgly-
oxal-derived glycation adducts within the pancreas predominantly 
localised to the extracellular matrix in vivo. We conclude that 
glycation of extracellular matrix collagen IV likely impairs adhesion 
of beta-cells to the extracellular matrix in pre-diabetes in vivo and 
may thereby contribute to beta-cell glucotoxicity and dysfunction 
with progression to type 2 diabetes mellitus.
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